Kurz gefasst
Fachartikel in der Zeitschrift Malignancy Spectrum, 2024.
Abstract (Originalsprache)
COVER : Zhang et al . found that fibroblast growth factor 21 (FGF21) increases the sensitivity of hepatocellular carcinoma (HCC) to sorafenib (SORA) by enhancing the phosphorylation of Smad3 through the phosphatidylinositol 3‐kinase/protein kinase B pathway under hypoxia, providing the possibility of combination therapy for SORA and FGF21 on HCC. See pages 99–112 for details.
Zitieren
APA
(2024). Issue Information. Malignancy Spectrum. https://doi.org/10.1002/msp2.36
Vancouver
Issue Information. Malignancy Spectrum. 2024. doi:10.1002/msp2.36
BibTeX
@article{euvimed2024,
title = {Issue Information},
journal = {Malignancy Spectrum},
year = {2024},
doi = {10.1002/msp2.36}
}
EUVIMED